{"id":22498,"date":"2022-12-02T07:30:30","date_gmt":"2022-12-02T07:30:30","guid":{"rendered":"https:\/\/fipmed.co\/lecba-fip-injekce-fip-vs-tablety-nebo-tablety-fip\/"},"modified":"2025-02-25T07:23:04","modified_gmt":"2025-02-25T07:23:04","slug":"lecba-fip-injekce-fip-vs-tablety-nebo-tablety-fip","status":"publish","type":"page","link":"https:\/\/fipmed.co\/cs\/lecba-fip-injekce-fip-vs-tablety-nebo-tablety-fip\/","title":{"rendered":"L\u00e9\u010dba FIP: Injekce FIP vs. tablety nebo tablety FIP"},"content":{"rendered":"

P\u0159i v\u00fdb\u011bru antivirotika GS-441524 pro l\u00e9\u010dbu FIP m\u00e1te dv\u011b mo\u017enosti: podko\u017en\u00ed injekce nebo peror\u00e1ln\u00ed kapsle \u010di tablety.
\nJak tedy vybrat tu vhodnou pro va\u0161i ko\u010dku?
\nV tomto p\u0159\u00edsp\u011bvku se budeme zab\u00fdvat v\u00fdhodami a nev\u00fdhodami jednotliv\u00fdch metod l\u00e9\u010dby a tak\u00e9 t\u00edm, kdy a jak se nejl\u00e9pe rozhodnout pro l\u00e9\u010dbu FIP va\u0161\u00ed ko\u010dky.
\nPeror\u00e1ln\u00ed l\u00e9ky jsou obvykle ve form\u011b tablet.
\nTento druh GS se u\u017e\u00edv\u00e1 peror\u00e1ln\u011b.
\nMajitel\u00e9 ko\u010dek si nyn\u00ed mohou<\/a> snadno vybrat nejlep\u0161\u00ed formu l\u00e9\u010dby<\/a> pro svou ko\u010dku, proto\u017ee je k dispozici v\u00edce mo\u017enost\u00ed.
\nRozd\u00edly mezi t\u011bmito 2 p\u0159\u00edpravky GS-441524 budou pops\u00e1ny v tomto p\u0159\u00edsp\u011bvku spolu s radami, jak vybrat ten nejlep\u0161\u00ed pro terapii FIP va\u0161\u00ed ko\u010dky.<\/p>\n

Injek\u010dn\u00ed l\u00e9\u010dba FIP<\/strong><\/h2>\n

Za\u010dn\u011bme diskus\u00ed o kapaln\u00e9 injek\u010dn\u00ed verzi p\u0159\u00edpravku GS-441524.
\nTato konkr\u00e9tn\u00ed forma GS je l\u00e9\u010diteln\u00e1.
\nR\u016fzn\u00e9 kapaliny GS-441524 maj\u00ed r\u016fzn\u00e9 vlastnosti.
\nV\u00fdrobn\u00ed technika a chemick\u00e1 kvalita pou\u017e\u00edvan\u00e1 v\u00fdrobcem maj\u00ed v\u00fdznamn\u00fd vliv na kvalitu.
\nSkute\u010dnost, \u017ee se ceny jednotliv\u00fdch zna\u010dek v\u00fdrazn\u011b li\u0161\u00ed, jen d\u00e1le prohlubuje nejistotu.
\nInjek\u010dn\u00ed forma p\u0159\u00edpravku GS441524 se dod\u00e1v\u00e1 v r\u016fzn\u00fdch koncentrac\u00edch.
\nNejobl\u00edben\u011bj\u0161\u00ed koncentrace, kter\u00e9 jsou nyn\u00ed k dispozici, jsou 20 mg a 30 mg.
\nNejlep\u0161\u00ed zp\u016fsob pod\u00e1v\u00e1n\u00ed GS-441524 je injek\u010dn\u00ed l\u00e9\u010dba.
\nSubkut\u00e1nn\u00ed injekce injekc\u00ed GS441524 okam\u017eit\u011b o\u0161et\u0159\u00ed krevn\u00ed ob\u011bh va\u0161\u00ed ko\u010dky antivirov\u00fdm l\u00e9kem.
\nL\u00e9ka\u0159i mohou pod\u00e1vat specifickou d\u00e1vku pomoc\u00ed injekc\u00ed na z\u00e1klad\u011b p\u0159\u00edznak\u016f a t\u011blesn\u00e9 hmotnosti va\u0161\u00ed ko\u010dky<\/a>.
\nKo\u010dky l\u00e9\u010den\u00e9 injekcemi \u010dasto vykazuj\u00ed zjevn\u00e9 zm\u011bny ji\u017e za jeden a\u017e \u010dty\u0159i dny.
\nProto jsou u ko\u010dek, kter\u00e9 vykazuj\u00ed z\u00e1va\u017en\u00e9 p\u0159\u00edznaky FIP<\/a>, injekce spr\u00e1vn\u00fdm a jedin\u00fdm \u00fa\u010dinn\u00fdm prost\u0159edkem l\u00e9\u010dby.
\nKa\u017ed\u00e1 l\u00e9\u010dba FIP by m\u011bla za\u010d\u00edt injekc\u00ed.
\nV pod\u00e1v\u00e1n\u00ed injekc\u00ed pokra\u010dujte, dokud se stav va\u0161\u00ed ko\u010dky nestabilizuje, a teprve a\u017e bude ko\u010dka spr\u00e1vn\u011b p\u0159ij\u00edmat potravu a vylu\u010dovat, m\u011bli byste uva\u017eovat o p\u0159echodu na peror\u00e1ln\u00ed l\u00e9\u010dbu.<\/p>\n

Peror\u00e1ln\u00ed l\u00e9\u010dba FIP (tablety nebo tablety)<\/strong><\/h2>\n

Ve srovn\u00e1n\u00ed s jehlami je peror\u00e1ln\u00ed l\u00e9\u010dba rychlej\u0161\u00ed a jednodu\u0161\u0161\u00ed technikou l\u00e9\u010dby FIP.
\nMajitel\u00e9 ko\u010dek si mohou pod\u00e1vat peror\u00e1ln\u00ed l\u00e9ky doma a vyhnout se tak ka\u017edodenn\u00edm n\u00e1v\u0161t\u011bv\u00e1m kliniky a v\u00fddaj\u016fm za injekce.
\nPro peror\u00e1ln\u00ed l\u00e9\u010dbu jsou k dispozici tablety a kapsle.
\nVzhledem k hladk\u00e9 struktu\u0159e a bez chuti kapsle mohou ko\u010dky kapsle obecn\u011b polykat snadn\u011bji ne\u017e tablety.
\nObecn\u011b doporu\u010dujeme vyu\u017e\u00edvat peror\u00e1ln\u00ed kapsle nebo tablety v pozd\u011bj\u0161\u00edch f\u00e1z\u00edch l\u00e9\u010dby, kdy ji\u017e ko\u010dce nehroz\u00ed nebezpe\u010d\u00ed, tj. kdy\u017e pravideln\u011b j\u00ed a chod\u00ed na z\u00e1chod a nem\u00e1 ji\u017e ob\u010dasn\u00e9 hore\u010dky.
\nNyn\u00ed probereme nev\u00fdhody peror\u00e1ln\u00ed l\u00e9\u010dby.
\nHlavn\u00edm rozd\u00edlem mezi peror\u00e1ln\u00ed a injek\u010dn\u00ed l\u00e9\u010dbou je rychlost jejich \u00fa\u010dinku.
\nAntivirov\u00fd l\u00e9k pou\u017e\u00edvan\u00fd p\u0159i peror\u00e1ln\u00ed l\u00e9\u010db\u011b, GS-441524, mus\u00ed proj\u00edt cel\u00fdm tr\u00e1vic\u00edm traktem, ne\u017e se dostane do krevn\u00edho ob\u011bhu.
\nNemo\u017enost kontroly d\u00e1vkov\u00e1n\u00ed je druhou hlavn\u00ed nev\u00fdhodou peror\u00e1ln\u00ed l\u00e9\u010dby.
\nNem\u016f\u017eeme p\u0159edpov\u011bd\u011bt, kolik z GS-441524 se vst\u0159eb\u00e1 v tr\u00e1vic\u00edm traktu va\u0161\u00ed ko\u010dky, co\u017e je d\u016fvod, pro\u010d.
\nVa\u0161e ko\u010dka m\u016f\u017ee vst\u0159ebat pouze ur\u010dit\u00e9 procento antivirotika dod\u00e1van\u00e9ho peror\u00e1ln\u00edmi kapslemi, v z\u00e1vislosti na stavu jej\u00edho tr\u00e1vic\u00edho syst\u00e9mu a celkov\u00e9ho zdravotn\u00edho stavu.
\nRychlost vst\u0159eb\u00e1v\u00e1n\u00ed GS bude ovlivn\u011bna oslaben\u00edm \u017ealudku, ledvin a jater, ke kter\u00e9mu doch\u00e1z\u00ed u ko\u010dek s ko\u010di\u010d\u00ed infek\u010dn\u00ed peritonitidou (FIP).
\nVe srovn\u00e1n\u00ed s injek\u010dn\u00edmi tabletami jsou peror\u00e1ln\u00ed tablety a tablety rizikov\u011bj\u0161\u00ed formou l\u00e9\u010dby.
\nTeprve po 30 dnech injek\u010dn\u00ed l\u00e9\u010dby nebo po stabilizaci stavu va\u0161\u00ed ko\u010dky navrhujeme peror\u00e1ln\u00ed l\u00e9\u010dbu.<\/p>\n

Bezpe\u010dnostn\u00ed opat\u0159en\u00ed pro kapsle<\/strong><\/h2>\n

V odv\u011btv\u00ed l\u00e9k\u016f FIP se p\u0159ev\u00e1\u017en\u011b pou\u017e\u00edvaj\u00ed ur\u010dit\u00e9 form\u00e1ty.
\nNap\u0159\u00edklad GS441524 jsou p\u0159ev\u00e1\u017en\u011b dostupn\u00e9 ve form\u011b tablet a EIDD2801 jsou dostupn\u00e9 ve form\u011b tobolek.
\nD\u00e1vejte si proto pozor na prodejce, kte\u0159\u00ed prod\u00e1vaj\u00ed GS441524 ve form\u011b tobolek.
\nTak\u00e9 d\u00e1vkov\u00e1n\u00ed GS441524 pro peror\u00e1ln\u00ed l\u00e9ky je standardizov\u00e1no na 15 mg na kg a na dvojn\u00e1sobnou d\u00e1vku pro o\u010dn\u00ed a neurologick\u00e9 typy.
\nNep\u0159ekra\u010dujte pros\u00edm toto d\u00e1vkov\u00e1n\u00ed, proto\u017ee vy\u0161\u0161\u00ed d\u00e1vka u peror\u00e1ln\u00edch l\u00e9k\u016f zhor\u0161uje vst\u0159ebatelnost.<\/p>\n

Srovn\u00e1n\u00ed injek\u010dn\u00ed a peror\u00e1ln\u00ed l\u00e9\u010dby <\/strong><\/h2>\n

Zde je tabulka, kter\u00e1 ukazuje rozd\u00edly mezi injek\u010dn\u00ed a peror\u00e1ln\u00ed l\u00e9\u010dbou FIP<\/a>. \"\"<\/p>\n

Jakou metodu m\u00e1m zvolit pro svou ko\u010dku?<\/strong><\/h2>\n

Podle na\u0161eho doporu\u010den\u00ed se doporu\u010duje zah\u00e1jit l\u00e9\u010dbu FIP injekcemi.
\nPokud opakovan\u00e9 injekce zp\u016fsobuj\u00ed akutn\u00ed bolest nebo siln\u00e9 podr\u00e1\u017ed\u011bn\u00ed k\u016f\u017ee, m\u016f\u017eete p\u0159ej\u00edt na peror\u00e1ln\u00ed tablety, jakmile se stav va\u0161\u00ed ko\u010dky stabilizuje.
\nPo 30 dnech injek\u010dn\u00ed l\u00e9\u010dby je p\u0159echod na peror\u00e1ln\u00ed l\u00e9\u010dbu obvykle bezpe\u010dn\u00fd.
\nJedn\u00e1 se o nejd\u016fv\u011bryhodn\u011bj\u0161\u00ed techniku, kter\u00e1 zaru\u010d\u00ed, \u017ee b\u011bhem l\u00e9\u010dby FIP bude pod\u00e1no dostate\u010dn\u00e9 mno\u017estv\u00ed GS-441524 a sn\u00ed\u017e\u00ed se riziko reinfekce v budoucnu.<\/p>\n

Faktory ovliv\u0148uj\u00edc\u00ed peror\u00e1ln\u00ed a injek\u010dn\u00ed pod\u00e1n\u00ed<\/strong><\/h2>\n

Ko\u010dky, kter\u00e9 v sou\u010dasn\u00e9 dob\u011b zvrac\u00ed\/regurgituj\u00ed a maj\u00ed pr\u016fjem, jsou obecn\u011b pova\u017eov\u00e1ny za \u0161patn\u00e9 kandid\u00e1ty na peror\u00e1ln\u00ed pod\u00e1n\u00ed GS-441524.
\nV d\u016fsledku toho ko\u010dky trp\u00edc\u00ed z\u00e1va\u017en\u00fdm gastrointestin\u00e1ln\u00edm onemocn\u011bn\u00edm \u010dasto za\u010d\u00ednaj\u00ed u\u017e\u00edvat injekce, p\u0159inejmen\u0161\u00edm do doby, ne\u017e se probl\u00e9my vy\u0159e\u0161\u00ed.
\nV\u011bt\u0161ina lid\u00ed, zejm\u00e9na v minulosti, za\u010d\u00ednala s injek\u010dn\u00edm GS-441524.
\nInjek\u010dn\u00ed forma je levn\u011bj\u0161\u00ed a d\u00e1vkov\u00e1n\u00ed je p\u0159esn\u011bji kontrolov\u00e1no.
\nSubkut\u00e1nn\u00ed absorpce GS-441524 je tak\u00e9 spolehliv\u011bj\u0161\u00ed ne\u017e absorpce peror\u00e1ln\u00ed, co\u017e je \u010dasto rozhoduj\u00edc\u00ed faktor p\u0159i po\u010d\u00e1te\u010dn\u00ed l\u00e9\u010db\u011b ko\u010dek, kter\u00e9 jsou na za\u010d\u00e1tku t\u011b\u017ece nemocn\u00e9 a nestabiln\u00ed.
\nTo, zda ko\u010dka bude v pod\u00e1v\u00e1n\u00ed injekc\u00ed GS-441524 pokra\u010dovat, z\u00e1vis\u00ed na schopnosti majitele \u00fa\u010dinn\u011b pod\u00e1vat injekce, na ochot\u011b ko\u010dky zvyknout si na bolestivost injekc\u00ed a na v\u00fdskytu v\u0159ed\u016f v m\u00edst\u011b vpichu.
\nV takov\u00fdch p\u0159\u00edpadech je peror\u00e1ln\u00ed l\u00e9\u010dba \u010dasto v\u00edtanou \u00falevou jak pro majitele, tak pro ko\u010di\u010d\u00edho pacienta.<\/p>\n

Srovn\u00e1n\u00ed \u00fasp\u011b\u0161nosti l\u00e9\u010dby injek\u010dn\u00edm a peror\u00e1ln\u00edm p\u0159\u00edpravkem GS-441524 <\/strong><\/h2>\n

\u00dasp\u011b\u0161nost peror\u00e1ln\u00edho GS-441524 se nyn\u00ed podob\u00e1 \u00fasp\u011b\u0161nosti injek\u010dn\u00edch verz\u00ed za p\u0159edpokladu, \u017ee jsou d\u00e1vky pe\u010dliv\u011b vypo\u010d\u00edt\u00e1ny<\/a> a d\u00e1vkov\u00e1n\u00ed je prov\u00e1d\u011bno efektivn\u011b.
\nByly v\u0161ak zaznamen\u00e1ny rozd\u00edly v reakc\u00edch mezi peror\u00e1ln\u00ed a injek\u010dn\u00ed formou GS-441524.
\nPouze u n\u011bkolika ko\u010dek do\u0161lo k recidiv\u011b po p\u0159echodu z injekc\u00ed na peror\u00e1ln\u00ed GS-441524 nebo na n\u011bj nereagovaly dob\u0159e jako na po\u010d\u00e1te\u010dn\u00ed l\u00e9\u010dbu.
\nP\u0159\u00edpadn\u011b bylo onemocn\u011bn\u00ed, kter\u00e9 nereagovalo dob\u0159e na injekce, l\u00e9\u010deno p\u0159eveden\u00edm ko\u010dek na peror\u00e1ln\u00ed GS-441524 v ekvivalentn\u00ed d\u00e1vce.
\nJe obt\u00ed\u017en\u00e9 p\u0159isuzovat tyto v\u00fdrazn\u00e9 rozd\u00edly v reakci na l\u00e9kovou formu, proto\u017ee GS-441524 se bu\u010f peror\u00e1ln\u011b, nebo subkut\u00e1nn\u011b dost\u00e1v\u00e1 do krevn\u00edho ob\u011bhu d\u0159\u00edve, ne\u017e se dostane do tk\u00e1n\u00ed.
\nJe pravd\u011bpodobn\u011bj\u0161\u00ed, \u017ee injek\u010dn\u00ed nebo peror\u00e1ln\u00ed zna\u010dky GS-441524 pou\u017e\u00edvan\u00e9 p\u0159ed t\u00edmto p\u0159echodem byly nevyhovuj\u00edc\u00ed.
\nV mnoha p\u0159\u00edpadech vedl p\u0159echod na jinou peror\u00e1ln\u00ed nebo injek\u010dn\u00ed zna\u010dku k okam\u017eit\u00e9mu zlep\u0161en\u00ed reakce.
\nProto\u017ee si virus vyvinul r\u016fzn\u00fd stupe\u0148 rezistence v\u016f\u010di l\u00e9k\u016fm, p\u0159edpokl\u00e1dalo se, \u017ee pouze injek\u010dn\u00ed forma GS-441524 m\u016f\u017ee dos\u00e1hnout mimo\u0159\u00e1dn\u011b vysok\u00fdch hladin v krvi a mozkom\u00ed\u0161n\u00edm moku, kter\u00e9 jsou nutn\u00e9 k \u00fa\u010dinn\u00e9 l\u00e9\u010db\u011b neurologick\u00e9ho onemocn\u011bn\u00ed.
\nKo\u010dky s neurologickou FIP v\u0161ak na p\u0159\u00edpravek Fipmed<\/a> reagovaly dob\u0159e.
\nKrom\u011b toho byly do t\u00e9to studie zahrnuty i n\u011bkter\u00e9 ko\u010dky, kter\u00e9 nereagovaly na mimo\u0159\u00e1dn\u011b vysok\u00e9 d\u00e1vky injek\u010dn\u00ed formy GS- 441524<\/a>.
\nZcela or\u00e1ln\u00ed re\u017eim l\u00e9\u010d\u00ed st\u00e1le v\u011bt\u0161\u00ed po\u010det zv\u00ed\u0159at s neurologickou FIP.
\nJe to bu\u010f d\u016fsledek v\u011bt\u0161\u00edch zku\u0161enost\u00ed s pou\u017e\u00edv\u00e1n\u00edm peror\u00e1ln\u00ed l\u00e9\u010dby FIP<\/a> v n\u00e1ro\u010dn\u00fdch p\u0159\u00edpadech, nebo, co\u017e je pravd\u011bpodobn\u011bj\u0161\u00ed, zlep\u0161en\u00ed kvality peror\u00e1ln\u00edho p\u0159\u00edpravku.<\/p>\n

Jak se pod\u00e1vaj\u00ed injekce GS?<\/strong><\/h2>\n

Subkut\u00e1nn\u011b, n\u011bkdy ozna\u010dovan\u00e9 jako „sub-cu“, je term\u00edn pro pod\u00e1n\u00ed injekce p\u0159\u00edmo pod k\u016f\u017ei.
\nKa\u017ed\u00fd den po dobu nejm\u00e9n\u011b 12 t\u00fddn\u016f mus\u00ed b\u00fdt injekce pod\u00e1v\u00e1ny t\u00e9m\u011b\u0159 ve stejnou dobu ka\u017ed\u00fdch 24 hodin.
\nSval ko\u010dky NESM\u00cd b\u00fdt jehlou prop\u00edchnut.
\nP\u0159i aplikaci GS injekce \u0161t\u00edpe, ale jakmile je injekce dokon\u010dena, nep\u0159\u00edjemn\u00e9 pocity ustanou.
\nNa\u0161i u\u017eivatel\u00e9 vytvo\u0159ili \u0159adu u\u017eite\u010dn\u00fdch film\u016f, na kter\u00fdch ukazuj\u00ed, jak injekci aplikuj\u00ed, a mnoho dal\u0161\u00edch je k dispozici na YouTube.
\nJe lep\u0161\u00ed, kdy\u017e v\u00e1m veterin\u00e1\u0159 aplikuje prvn\u00ed jednu nebo dv\u011b injekce a uk\u00e1\u017ee v\u00e1m, jak je aplikovat.
\nU ko\u010dek, kter\u00e9 je obt\u00ed\u017en\u011bj\u0161\u00ed znehybnit kv\u016fli injekc\u00edm, m\u016f\u017ee b\u00fdt nutn\u00e1 ka\u017edodenn\u00ed n\u00e1v\u0161t\u011bva veterin\u00e1\u0159e.<\/p>\n

Z\u00e1v\u011br<\/h2>\n

Majitel\u00e9 ko\u010dek by proto m\u011bli v\u017edy za\u010d\u00edt s injek\u010dn\u00ed metodou l\u00e9\u010dby FIP a p\u0159ibli\u017en\u011b po 30 dnech p\u0159ej\u00edt na u\u017e\u00edv\u00e1n\u00ed tablet v z\u00e1vislosti na stavu ko\u010dky.
\nU\u017e\u00edv\u00e1n\u00ed l\u00e9k\u016f prost\u0159ednictv\u00edm injekc\u00ed nebo peror\u00e1ln\u00ed u\u017e\u00edv\u00e1n\u00ed l\u00e9k\u016f m\u00e1 sv\u00e9 v\u00fdhody i nev\u00fdhody a je na veterin\u00e1\u0159\u00edch a majitel\u00edch ko\u010dek, aby zvolili lep\u0161\u00ed \u0159e\u0161en\u00ed z t\u011bchto dvou, kter\u00e9 poskytnou ko\u010dk\u00e1m posti\u017een\u00fdm FIP.<\/p>\n","protected":false},"excerpt":{"rendered":"

P\u0159i v\u00fdb\u011bru antivirotika GS-441524 pro l\u00e9\u010dbu FIP m\u00e1te dv\u011b mo\u017enosti: podko\u017en\u00ed injekce nebo peror\u00e1ln\u00ed kapsle \u010di tablety. Jak tedy vybrat tu vhodnou pro va\u0161i ko\u010dku? V tomto p\u0159\u00edsp\u011bvku se budeme zab\u00fdvat v\u00fdhodami a nev\u00fdhodami jednotliv\u00fdch metod l\u00e9\u010dby a tak\u00e9 t\u00edm, kdy a jak se nejl\u00e9pe rozhodnout pro l\u00e9\u010dbu FIP va\u0161\u00ed ko\u010dky. Peror\u00e1ln\u00ed l\u00e9ky jsou obvykle […]<\/p>\n","protected":false},"author":11,"featured_media":22500,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_glsr_average":0,"_glsr_ranking":0,"_glsr_reviews":0,"footnotes":""},"categories":[849],"tags":[850,895],"_links":{"self":[{"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/pages\/22498"}],"collection":[{"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/comments?post=22498"}],"version-history":[{"count":1,"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/pages\/22498\/revisions"}],"predecessor-version":[{"id":29256,"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/pages\/22498\/revisions\/29256"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/media\/22500"}],"wp:attachment":[{"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/media?parent=22498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/categories?post=22498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fipmed.co\/cs\/wp-json\/wp\/v2\/tags?post=22498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}